Synergy Rx Review: A Good Ladder, the Wrong Peptide

Synergy Rx sells compounded sermorelin at $275 a month, month-to-month, with a commitment ladder underneath it that behaves the way a ladder is supposed to: $525 for three months, $899 for six, $1,599 for twelve — about $133 a month at the bottom. It publishes those figures, it sells the month-to-month rung rather than dangling it, and by the standards of this category that is a straightforward proposition.

We still cannot recommend it, and the reason has nothing to do with price.

The finding: its own product page has the wrong molecule

Synergy Rx sells PT-141 (bremelanotide). PT-141 is a melanocortin-receptor agonist prescribed for sexual dysfunction. Synergy's product description for it says that PT-141 is a peptide that increases the body's natural production of growth hormone, and lists increased lean muscle mass, decreased body fat and improved sleep among its effects.

That is not what PT-141 does. That is the description of sermorelin, pasted onto a different drug.

We are naming it rather than working around it because on a site about growth-hormone peptides this is the most load-bearing thing we found. A buyer who reads that page could reasonably conclude that PT-141 is a GH secretagogue and buy it for sleep or body composition, and they would be buying a drug that does neither. Nothing on this page or anywhere on this site repeats that claim as true. If you want the actual distinction between peptides that raise GH and peptides that do not, that is what our sermorelin ranking and the evidence pages behind it exist for.

How it happened is not mysterious. Synergy runs on a white-label telehealth platform shared by several brands we track, and the product descriptions are byte-identical across those brands. Shared copy is cheap and it works fine — right up until a paragraph gets attached to the wrong SKU, at which point the mistake propagates everywhere the copy goes. The practical consequence for you is narrower than "the company is careless": it is that the clinical copy on this site is not independent evidence of anything, because it was not written for this site's products.

The pricing, which is genuinely fine

Read from the company's own product bundle:

• •Sermorelin injection — $275/month month-to-month; $525 for three months ($175/mo), $899 for six ($150/mo), $1,599 for twelve ($133/mo).
• •NAD+ injection — $275/month, on the same ladder.
• •Glutathione injection, 200 mg/mL — $275/month.
• •B-12 methylcobalamin — $109/month.

Two things stand out. First, the month-to-month rung is real and purchasable, so the ladder is a choice rather than a floor you have to buy your way down to — the opposite of the prepay-as-headline pattern that catches readers out across this category. Second, the discount is steep: $275 to $133 is a genuine 52% for a year's commitment. Against the wider spread in what sermorelin costs per month, $275 sits high month-to-month and $133 sits near the bottom of the market.

Worth knowing if you were also considering its weight-loss line: Synergy's GLP-1 ladder runs the wrong way. Its three-month bundles cost more per month than paying monthly. That does not affect the peptide side, but it does tell you the ladders are set per product rather than by a coherent policy.

And a qualifier that applies to every figure above. Synergy's terms warn that the final charge to your card may fluctuate depending on the medication prescribed and the pharmacy chosen. So the published prices are not binding. Ask what your prescribed dose costs before you authorise anything.

The guarantee that its own terms cancel

Synergy's about page advertises a money-back guarantee. Its terms say that medical consult fees are not subject to or eligible for a refund and that all sales are final.

Those cannot both be true, and the terms are the binding document. Alongside them: governing law in Georgia, arbitration in Fulton County, and a class-action and jury waiver with a 30-day opt-out. A site-wide welcome credit and a promotional banner run with no published terms at all, and the patient-count claim on the homepage has nothing behind it.

The disclosure is real — and it is not Synergy's own

Correction, and it matters. An earlier version of this review said Synergy Rx names no compounding pharmacy and no individual clinician. That was wrong, and it was wrong in the way negative claims usually are: it was our search coming up empty rather than the company being silent. Synergy's homepage FAQ names four dispensing pharmacies with phone numbers — Belmar, Strive, Epiq Scripts and Casa Pharma Rx — and two prescribing physicians of the Lion MD group, Dr Ana Lisa Carr MD (NPI 1689841744) and Dr Kelly Tenbrink MD (NPI 1346482684), both of which we could verify. Its `/about` page also publishes unlimited 24/7 support with unlimited appointments and messaging included.

That clears two of the three non-negotiables in our guide to vetting a sermorelin provider, and it puts Synergy among the seven rows on that board that name a dispensing pharmacy at all rather than outside them.

The real finding is narrower and more interesting than the false one. That text is byte-identical to what its white-label siblings publish. Synergy runs on a shared telehealth backend, and the same four pharmacies, the same two physicians and the same wording appear on every brand running it. So the disclosure is genuine — those pharmacies really do fill these prescriptions, and those NPIs are real — but it describes the platform, not the brand. One brand's clinical bench is never corroboration for another's, and finding the same names on four storefronts is not four independent confirmations. It is one, repeated.

Note also what Synergy does not claim: it makes no 503A representation about those pharmacies. We do not credit it with one it has not made.

Two things it genuinely does not publish:

• •No state list. The terms say the service is available in certain states and tell you to contact customer service for the current list. Product-level exclusions do exist and are more informative than the terms: glutathione, B-12 and the skincare line carry an eleven-state no-ship list, NAD+ in those eleven is filled by secondary pharmacies at a cost that may vary, and sermorelin is filled through a secondary pharmacy in one further state. If you see a "50 states" claim for this company anywhere, it is unsupported by anything Synergy publishes.
• •No dose strength. The sermorelin price is not attached to a milligram figure, though a sibling brand on the same backend publishes its own. So $275 cannot be compared per milligram against providers that do.

Synergy also names its operating entity and its medical group, and carries a certification seal we were able to verify. We screened the company, its trading name, its medical group and its platform operator against the FDA warning-letter database on 8 August 2026, on a search validated against a known positive in the same pass¹. Nothing is on record for any of them.

What sermorelin actually does, since the site next door got it wrong

Sermorelin is GHRH(1-29). It prompts the pituitary to release its own growth hormone in pulses rather than replacing the hormone, and it raises GH and IGF-1 reliably in the short term²³. The sleep claim is the best-supported part of the pitch and it is genuinely measured: GHRH given to healthy men increases slow-wave sleep alongside the GH pulse⁴, and GHRH's role in sleep regulation is well described⁵. The response weakens with age, which is worth knowing before you buy an anti-aging framing⁶.

What does not exist is a modern long-term outcome trial in healthy adults⁷, and there is no FDA-approved finished sermorelin product in the US, so every legitimate prescription is compounded⁸. That applies here as everywhere. If sleep is your reason for being interested, peptides for sleep is where we set out which molecules have anything behind them and which do not — and PT-141 is not among them, whatever Synergy's page says.

Who it suits

It suits a reader who already knows exactly what they want, is buying on price and terms rather than on the site's guidance, and is planning to commit for six or twelve months — where $150 or $133 a month is competitive. It also suits someone who wants sermorelin, NAD+ and glutathione on one account, which is a deeper longevity line than most.

It suits you less if you were hoping to learn anything from the product pages, if you need to know your state is covered before you pay, if you want a dose attached to the price, or if the money-back guarantee was part of why you were considering it — because the terms say all sales are final.

Bottom line

$275 a month month-to-month, falling to $133 on a year, with a real published ladder and a purchasable monthly rung — that part is fine, and better than several better-known names. It names four pharmacies with phone numbers and two physicians with verifiable NPIs, putting it among the seven rows on this board that name a pharmacy at all, with the caveat that the same names appear word for word on every brand sharing its backend, so they describe the platform rather than this company. Everything else needs care: the published prices are explicitly not binding, the advertised money-back guarantee is contradicted by an all-sales-final term, there is no state list and no dose behind the price. And its own PT-141 page attributes sermorelin's mechanism and sermorelin's benefits to a drug that has neither. Buy the price if you want it; do not buy the pharmacology.